Xenometrix AG (Allschwil, Switzerland) is the leading specialist manufacturer of in vitro genotoxicity and mutagenicity testing systems for the pharmaceutical, chemical, cosmetics, food, and water quality testing industries.
Aniara Diagnostica is the North American distributor for the complete Xenometrix product portfolio across the United States and Canada.
Xenometrix test systems cover the full in vitro genotoxicity testing battery as recommended by ICH S2(R1), OECD, and ISO guidelines — including bacterial reverse mutation (Ames) tests in miniaturized liquid-format (Ames MPF™), fluctuation test format (Ames II™), and traditional MacroAmes plate format; SOS genotoxicity testing with the umuC assay per ISO 13829; chromosomal aberration testing with the Rapid Micronucleus MoA kit; endocrine disruptor screening with XenoScreen YES and YAS yeast-based assays; and cell viability measurement with the XTT assay.
Complete kits include tester strains, S9 metabolic activation fractions, media, and all controls required for validated regulatory studies.